ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Simple Search Results

Didn't find what you were looking for? Try the Advanced Search »

  • « Previous Page
  • 1
  • …
  • 80
  • 81
  • 82
  • 83
  • 84
  • …
  • 96
  • Next Page »
Search Again »
  • Abstract Number: 2109 • 2017 ACR/ARHP Annual Meeting

    Hyperferritinemic Syndrome in a General Hospital

    Ignacio Javier Gandino1, Florencia Pierini2, Jose Maximiliano Martinez P3, Santiago Ruta2, Marina Scolnik2 and Enrique R Soriano4, 1Reumatologia, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, 2Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, CABA, Argentina, 3Rheumatology, Internal Medicine Service, Rheumatology Unit, Internal Medicine Service, Hospital Italiano de Buenos Aires, Instituto Universitario Hospital Italiano de Buenos Aires, and Fundacion PM Catoggio, Buenos Aires, Argentina, 4Argentina, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina

    Background/Purpose: Hyperferritinemia is associated with inflammatory conditions, such as rheumatologic diseases. Objectives: To determine which diseases are associated with hyperferritinemia in a tertiary hospital; to…
  • Abstract Number: 2216 • 2017 ACR/ARHP Annual Meeting

    Are Adults with Arthritis Advised to Exercise By Their Health Care Providers? National Health Interview Survey, 2002 and 2014

    Jennifer M. Hootman1, Louise Murphy2, Michael Boring3 and Teresa J. Brady3, 1Centers for Disease Control and Prevention, Kennesaw, GA, 2Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA, 3Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA

    Background/Purpose: Most published clinical practice guidelines for the management of osteoarthritis recommend exercise as a primary self-management strategy. Despite this, less than one-third of primary…
  • Abstract Number: 2347 • 2017 ACR/ARHP Annual Meeting

    High Interferon (IFN) Signatures and Overlapping Clinical Features Characterize Subgroups of Patients with Presumed IFN-Mediated Autoinflammatory Diseases

    Adriana Almeida de Jesus1, Yanfeng Hou2, Louise Malle1, Scott Canna3, Stephen R. Brooks4, Hanna Kim5, Gina A. Montealegre Sanchez1, Rachel VanTries1, Angélique Biancotto6, Samantha Dill5, Dawn C. Chapelle5, Bernadette Marrero1, Yan Huang1 and Raphaela Goldbach-Mansky1, 1Translational Autoinflammatory Disease Studies (TADS), Laboratory of Clinical Investigation and Microbiology (LCIM), NIAID/NIH, Bethesda, MD, 2Department of Rheumatology, Shandong Provincial Qianfoshan Hospital, Shandong University, Shandong, China, 3Richard King Mellon Foundation Institute for Pediatric Research, Children's Hospital of Pittsburgh, Pittsburrgh, PA, 4Biodata Mining and Discovery Section, Office of Science and Technology, NIAMS/NIH, Bethesda, MD, 5Pediatric Translational Research Branch, NIAMS/NIH, Bethesda, MD, 6Center for Human Immunology, Autoimmunity and Inflammation (CHI), NHLBI, NIH, Bethesda, MD

    Background/Purpose: Many pediatric patients (pts.) with early-onset autoinflammatory disease (AID) phenotypes are mutation-negative for genetically known AIDs. Recent data suggest a role for Type-I interferon…
  • Abstract Number: 2601 • 2017 ACR/ARHP Annual Meeting

    Novel Anti-Malarial Drug Derivative Inhibited Type I Interferon Production and Autoimmune Inflammation in SLE Patient PBMC and in Trex1-/- Mouse Spleen and Heart

    Jie An1, Weinan Lai2,3, Joshua Woodward4, Xizhang Sun1, Lena Tanaka1, Tomikazu Sasaki5 and Keith B. Elkon6, 1Division of Rheumatology, University of Washington, Seattle, WA, 2Department of Medicine/Division of Rheumatology, University of Washington, Seattle, WA, 3Department of Rheumatology, Nanfang Hospital, Southern Medical University, Guangzhou, China, 4Department of Microbiology, University of Washington, Seattle, WA, 5Department of Chemistry, University of Washington, Seattle, WA, 6Division of Rheumatology, Department of Medicine, University of Washington, Seattle, WA

    Background/Purpose: Type I interferon (IFN-I) is strongly implicated in the pathogenesis of Systemic Lupus Erythematosus (SLE) as well as rare monogenic ‘interferonopathies’ such as Aicardi-Goutieres…
  • Abstract Number: 2826 • 2017 ACR/ARHP Annual Meeting

    Fine-Mapping Identifies Causal Variants for RA and T1D in DNASE1L3, Sirpg, MEG3, TNFAIP3 and CD28/CTLA4 Loc

    Harm-Jan Westra1, Marta Martinez-Bonet2, Suna Onengut3, Annette Lee4, Yang Luo1, Nikola Teslovich1, Jane Worthington5, Javier Martín6, TWJ Huizinga7, Lars Klareskog8, Solbritt Rantapää Dahlqvist9, Wei-Min Chen3, Aaron Quinlan10, John Todd11, Stephen Eyre5, Peter Nigrovic2, Peter Gregersen4, Stephen Rich3 and Soumya Raychaudhuri12, 1Division of Genetics and Rheumatology, Department of Medicine, Harvard Medical School, Boston, MA, 2Division of Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 3Department of Public Health Sciences, University of Virginia, Charlottesville, VA, 4The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY, 5Arthritis Research UK Centre for Genetics and Genomics, Centre for Musculoskeletal Research, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom, 6Instituto de Parasitología y Biomedicina López-Neyra, IPBLN-CSIC, PTS-Granada, Granada, Spain, 7Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 8Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden, 9University of Umeå, Umeå, Sweden, 10Department of Human Genetics, University of Utah, Salt Lake City, UT, 11JDRF/Wellcome Trust Diabetes and Inflammation Laboratory, Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom, 12Division of Medicine and Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

    Background/Purpose: While genome-wide association studies have identified risk loci for rheumatoid arthritis and other autoimmune diseases, in very few instances have causal variants driving risk…
  • Abstract Number: 2899 • 2017 ACR/ARHP Annual Meeting

    Trapped Crystals in Synovial Fluid: Neutrophil Extracellular Traps (NETs) from Bench to Bed-Side

    Estrella Garcia Gonzalez, Orso Maria Luccherini, Alessandra Gamberucci, Alessandra Ali, Antonella Simpatico, Sauro Lorenzini, Marco Bardelli, Mauro Galeazzi and Enrico Selvi, Rheumatology Unit - Policlinico le Scotte, Siena, Italy

    Background/Purpose: Recent data show that neutrophils are able to release chromatin and granular enzymes in web-like structures called neutrophil extracellular traps (NETs). The release of NETs has a physiological…
  • Abstract Number: 2901 • 2017 ACR/ARHP Annual Meeting

    Anti-Inflammatory Mechanism of Lubricin/Proteoglycan 4 (PRG4) in Monosodium Urate (MSU)-Crystal Induced Arthritis in THP-1 Macrophages Is Mediated By NALP3 Inflammasome.

    Anthony M. Reginato1, Changqi Sun2, Tannin Schmidt3, Elsaid Khalid4 and Gregory Jay5, 1Division of Rheumatology, The Warren Alpert School Of Medicine of Brown University, Providence, RI, 2Division of Rheumatology, Rhode Island Hosital/The Warren Alpert School of Medicine of Brown University, Providence, RI, 3Kinesiology and Schulich School of Engineering, University of Calgary, Calgary, AB, Canada, 4Department of Biomedical and Phramaceutical Science, Chapman University School of Pharmacy, Irvine, CA, 5Emergency Medicine and Engineering, The Warren Alpert Medical School Brown University, Providence, RI

    Background/Purpose: Lubricin/proteoglycan-4 (PRG4) is a mucinous glycoprotein secreted by synovial fibroblast and superficial zone chondrocytes. PRG4 has a multifaceted homeostatic role in the joint including…
  • Abstract Number: 2987 • 2017 ACR/ARHP Annual Meeting

    Moderate and Serious Psychological Distress Among US Adults with and without Arthritis, 2002 to 2015

    Louise Murphy1, Michael Boring2, Teresa J. Brady3, Kristina Theis4, Jennifer M. Hootman5, Kamil E. Barbour3 and Charles G. Helmick4, 1Division of Population Health, Centers for Disease Control and Prevention, Atlanta, GA, 2Cutting Edge Technology and Solutions, Mesa, AZ, 3Arthritis Program, Centers for Disease Control and Prevention, Atlanta, GA, 4Centers for Disease Control and Prevention, Atlanta, GA, 5Centers for Disease Control and Prevention, Kennesaw, GA

    Background/Purpose: US population-health surveys frequently measure current mental health status using the Kessler-6 (K-6) which indicates psychological distress level. Among all US adults, moderate and…
  • Abstract Number: 39 • 2017 Pediatric Rheumatology Symposium

    Rheumapalooza:  A rheumatology curriculum in evolution

    Kristen Hayward1 and Helen M. Emery2, 1Pediatric Rheumatology, University of Washington & Seattle Children's Hospital, Seattle, WA, 2rheumatology, Seattle Childrens Hospital, Seattle, WA

    Background/Purpose: Rheumapalooza was implemented in 2008 as an elective course with support from an ACR/REF Clinical Scholar Educator Award.1 The course was incorporated into the…
  • Abstract Number: 151 • 2017 Pediatric Rheumatology Symposium

    Severe Phenotype of Mevalonate-kinase Deficiency in the Czech Republic

    Sarka Fingerhutova1, Lenka Dvorakova2, Petr Chrastina2, Eva Jancova3, Petra Keslova4, Adam Klocperk5, Marcel Schuller6, Alexander Kolsky7 and Pavla Dolezalova1, 1Paediatric Rheumatology Unit, General University Hospital in Prague and 1st Faculty of Medicine, Charles University, General University Hospital in Prague and 1st Faculty of Medicine, Prague, Czech Republic, 2Institute of Inherited Metabolic Disorders, Institute of Inherited Metabolic Disorders, 1 st Faculty of Medicine Charles University and General University Hospital in Prague, Prague, Czech Republic, 3Department of Nephrology, General University Hospital in Prague and 1st Faculty of Medicine, Prague, Czech Republic, 4Department of Paediatric Haematology and Oncology, 2 nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, 2 nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic, 5Department of Immunology, 2 nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, 2 nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic, 6Paediatric Rheumatology Unit, University Hospital Brno, Brno, Czech Republic, 7Department of Children and Adolescents, 3 rd Faculty od Medicine, Charles University in Prague, Prague, Czech Republic

    Background/Purpose:  Disease phenotype of mevalonate-kinase (MVK) deficiency (MKD) varies in relation to the extent of enzymatic activity reduction. It ranges from multi-organ involvement with fatal…
  • Abstract Number: 116 • 2016 ACR/ARHP Annual Meeting

    Racial Differences in Self-Reported Pain and Disability: A Longitudinal Study of Knee Osteoarthritis

    Ernest Vina1, Di Ran2, Erin Ashbeck2 and C. Kent Kwoh3, 1Rheumatology, University of Arizona, Tucson, AZ, 2University of Arizona, Tucson, AZ, 3Rheumatology, University of Arizona, College of Medicine, Tucson, AZ

    Background/Purpose:   Pain and disability from knee osteoarthritis (KOA) has been reported to be greater among African-Americans (AAs) than Whites (WHs), though progression in KOA-related…
  • Abstract Number: 136 • 2016 ACR/ARHP Annual Meeting

    The 7-Joints Musculoskeletal Ultrasound Score (US7 score) Predicts Therapeutic Change in Patients with Early Rheumatoid Arthritis

    Sarah Ohrndorf1, Philipp Daniel Oberdorfer2, Lien Le3, Ulrich Mansmann3, Lisa Ines Sprenger2, Thomas Häupl4, Sandra Hermann2, Gabriela Schmittat2, Silvia Pade2, GR Burmester5, Anne-Marie Glimm2 and Marina Backhaus6, 1Rheumatology and Clinical Immunology, Charité-University Medicine Berlin, Berlin, Germany, 2Department of Rheumatology and Clinical Immunology, Charité University Medicine Berlin, Berlin, Germany, 3Institut für medizinische Informationsverarbeitung, Biometrie und Epidemiologie, Ludwig-Maximilians-Universität Munich, Munich, Germany, 4Department of Rheumatology and Clinical Immunology, Charité University Medicine, Berlin, Germany, 5Charité – University Medicine Berlin, Berlin, Germany, 6Department of Rheumatology & Immunology, University Medicine Charit, Berlin, Germany

    Background/Purpose: Treatment decisions in patients with Rheumatoid Arthritis (RA) after the “Treat to Target (T2T)” - principle is widely recommended, as this management strategy leads…
  • Abstract Number: 153 • 2016 ACR/ARHP Annual Meeting

    Synovial Immunophenotype and Ultrasonography: A Contemporaneous Study of Different Compartments of the Knee Joint

    Aurélie Najm1,2, Carl Orr3, Benoît Le Goff MD PhD1, Ursula Fearon4 and Douglas J. Veale5, 1Rheumatology, Nantes University Hospital, Nantes, France, 2Rheumatology, Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin, Ireland, 3Centre for Arthritis and Rheumatic Diseases, Dublin Academic Medical Centre, University College Dublin, Dublin 4, Ireland, 4Trinity College Dublin, Department of Molecular Rheumatology, Trinity College Dublin, Dublin, Ireland, 5Consultant Rheumatologist, Centre for Arthritis and Rheumatic Disease, St. Vincent’s University Hospital and University College Dublin, Dublin 4, Ireland

    Background/Purpose: Histological analysis of synovial tissue, despite being a reliable and accurate assessment for synovitis, is not routinely performed. Ultrasonography (US) is a fast, available…
  • Abstract Number: 190 • 2016 ACR/ARHP Annual Meeting

    Pharmacokinetics, Pharmacodynamics, and Tolerability of Verinurad, a Selective Uric Acid Reabsorption Inhibitor, in Healthy Adult Male Subjects

    Michael Gillen1, Zangong Shen2 and Jeffrey N. Miner3, 1AstraZeneca, Gaithersburg, MD, 2Ardea Biosciences, San Diego, CA, 3Discovery Biology, Ardea Biosciences, Inc., San Diego, CA

    Background/Purpose:  This was a Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-ascending dose study. Panels of 8 male subjects (6 active, 2 placebo) received a…
  • Abstract Number: 191 • 2016 ACR/ARHP Annual Meeting

    Pharmacokinetics, Pharmacodynamics, and Tolerability of Concomitant Multiple Dose Administration of Verinurad (RDEA3170) and Febuxostat in Healthy Adult Male Subjects

    James VanderLugt1, Michael Gillen2, Xiaojuan Yang3 and Jesse Hall3, 1Jasper Clinical Research & Development, Kalamazoo, MI, 2AstraZeneca, Gaithersburg, MD, 3Ardea Biosciences, Inc., San Diego, CA

    Background/Purpose: Verinurad (RDEA3170) is a novel selective uric acid reabsorption inhibitor in clinical development for the treatment of gout and asymptomatic hyperuricemia. This Phase 1,…
  • « Previous Page
  • 1
  • …
  • 80
  • 81
  • 82
  • 83
  • 84
  • …
  • 96
  • Next Page »
Search Again »

Didn't find what you were looking for? Try the Advanced Search »

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology